Ankit Mahadevia - Net Worth and Insider Trading
Ankit Mahadevia Net Worth
The estimated net worth of Ankit Mahadevia is at least $865,357 dollars as of 2024-12-01. Ankit Mahadevia is the Director of Spero Therapeutics Inc and owns about 759,085 shares of Spero Therapeutics Inc (SPRO) stock worth over $865,357. Details can be seen in Ankit Mahadevia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ankit Mahadevia has not made any transactions after 2024-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ankit Mahadevia
Ankit Mahadevia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ankit Mahadevia owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .
Click here to see the complete history of Ankit Mahadevia’s form 4 insider trades.
Insider Ownership Summary of Ankit Mahadevia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2024-08-27 | director & See Remarks |
Ankit Mahadevia Latest Holdings Summary
Ankit Mahadevia currently owns a total of 1 stock. Ankit Mahadevia owns 759,085 shares of Spero Therapeutics Inc (SPRO) as of August 27, 2024, with a value of $865,357.
Latest Holdings of Ankit Mahadevia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2024-08-27 | 759,085 | 1.14 | 865,357 |
Holding Weightings of Ankit Mahadevia
Ankit Mahadevia Form 4 Trading Tracker
According to the SEC Form 4 filings, Ankit Mahadevia has made a total of 11 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 5,912 shares on August 27, 2024, which brought Ankit Mahadevia around $7,981.
Insider Trading History of Ankit Mahadevia
- 1
Ankit Mahadevia Trading Performance
Ankit Mahadevia Ownership Network
Ankit Mahadevia Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Ankit Mahadevia is the director & See Remarks of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , Chief Financial Officer Sath Shukla , and Chief Medical Officer Kamal Hamed .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Ankit Mahadevia made 3 insider transaction in Spero Therapeutics Inc (SPRO) with a net sale of 78,747. Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 35,038 shares made by Timothy Keutzer , and a net sale of 67,571 shares made by Kamal Hamed .
In summary, during the past 3 months, insiders sold 40,596 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 40,596 shares. During the past 18 months, 371,921 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 371,921 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Ankit Mahadevia Mailing Address
Above is the net worth, insider trading, and ownership report for Ankit Mahadevia. You might contact Ankit Mahadevia via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Ave., 14th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
